Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Goodwill & Intangibles (2021 - 2025)

Historic Goodwill & Intangibles for Relay Therapeutics (RLAY) over the last 5 years, with Q1 2025 value amounting to $2.3 million.

  • Relay Therapeutics' Goodwill & Intangibles changed 0.0% to $2.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.3 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.3 million for FY2024, which is 0.0% changed from last year.
  • Per Relay Therapeutics' latest filing, its Goodwill & Intangibles stood at $2.3 million for Q1 2025, which was down 0.0% from $2.3 million recorded in Q4 2024.
  • In the past 5 years, Relay Therapeutics' Goodwill & Intangibles ranged from a high of $2.3 million in Q2 2021 and a low of $2.3 million during Q2 2021
  • Over the past 5 years, Relay Therapeutics' median Goodwill & Intangibles value was $2.3 million (recorded in 2021), while the average stood at $2.3 million.
  • The largest annual percentage gain for Relay Therapeutics' Goodwill & Intangibles in the last 5 years was 0.0% (2022), contrasted with its biggest fall of 0.0% (2022).
  • Over the past 5 years, Relay Therapeutics' Goodwill & Intangibles (Quarter) stood at $2.3 million in 2021, then changed by 0.0% to $2.3 million in 2022, then changed by 0.0% to $2.3 million in 2023, then changed by 0.0% to $2.3 million in 2024, then changed by 0.0% to $2.3 million in 2025.
  • Its Goodwill & Intangibles stands at $2.3 million for Q1 2025, versus $2.3 million for Q4 2024 and $2.3 million for Q3 2024.